Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
IntroductionInsulin-like growth factor binding protein-3 (IGFBP-3) exerts varying effects on estrogen receptor alpha (ERα)-positive and triple-negative breast cancer (TNBC) cells. In ERα-positive cells, IGFBP-3 is antiproliferative and proapoptotic. In contrast, IGFBP-3 stimulates proliferation in t...
Saved in:
| Main Authors: | Keenan L. Flynn, Yan Zheng, Janel Y. Sowers, Nefretiri J. T. Masangya, Kevin D. Houston |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1452981/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of dasatinib and quercetin promotes osteogenic differentiation and stemness maintenance of hPDLSCs via YAP/TAZ
by: Yunge Qiu, et al.
Published: (2025-12-01) -
Non-monotonic response of macrophages to mechanical stretch impacts skin wound healing
by: Qian Wei, et al.
Published: (2025-07-01) -
The components and regulation of the Hippo pathway and its relationships with the progression and treatment of Non-small cell lung cancer (NSCLC)
by: Yuheng Feng, et al.
Published: (2025-08-01) -
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
by: Ruize Gao, et al.
Published: (2021-10-01) -
Comparative study of three vaginal markers of the premature rupture of membranes: Insulin like growth factor binding protein 1 Diamine‐oxidase pH
by: Pascal Gaucherand, et al.
Published: (1997-06-01)